Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates

Prognostic and predictive factors for early and late distant distance recurrence risk in estrogen-receptor positive and HER2-receptor negative early breast cancer are well known, but not all these variables work equally for the prediction. The following are the most widely accepted variables for cat...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Hurtado, Daniel, Rivero, Sergio, Samamé Pérez-Vargas, Juan Carlos, Petracci, Fernando E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Current and Future Prospective of Breast Cancer Treatment and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450458/
https://www.ncbi.nlm.nih.gov/pubmed/37637230
http://dx.doi.org/10.1177/11782234231192780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450458/
https://www.ncbi.nlm.nih.gov/pubmed/37637230
http://dx.doi.org/10.1177/11782234231192780

Ejemplares similares